局部抗生素递送系统预防植入物乳房再造感染的证据综述
本文系统综述了局部抗生素递送系统在植入物乳房再造中预防感染的效果。纳入6项研究,涉及硫酸钙抗生素珠、聚甲基丙烯酸甲酯抗生素板和术后持续抗生素冲洗,初步显示可降低感染率和植入物丢失率,但回顾性设计限制结论确定性。
要点
- 硫酸钙抗生素珠显著降低植入物丢失率(1.6% vs 9.4%,P=0.031;1.5% vs 11.9%,P=0.024)。
- 聚甲基丙烯酸甲酯抗生素板显著降低SSI率(12.6%→4.8%,P<0.01;14%→4%,P=0.047)。
- 持续术后抗生素冲洗降低SSI(6.4%→1.9%,P=0.007)和取出率(20%→2.9%,P=0.037),但血清肿率升高(4.7% vs 1.4%,P=0.033)。
核心结论
- 初步研究提示局部抗生素递送可能降低乳房再造中的感染和植入物丢失,但回顾性设计和方法学局限使结论尚不确定。
研究设计与样本
- 遵循PRISMA指南的系统综述,检索Medline、Cochrane和Embase(1990-2025年),最终纳入6项研究。
主要发现
- 两项硫酸钙可降解抗生素珠研究显示植入物丢失率显著降低(1.6% vs 9.4%,P=0.031;1.5% vs 11.9%,P=0.024)。
- 两项聚甲基丙烯酸甲酯抗生素板研究显示SSI率显著降低(12.6%→4.8%,P<0.01;14%→4%,P=0.047),植入物丢失率显著降低(6% vs 18%,P=0.036)。
- 持续术后抗生素冲洗研究显示SSI率降低(6.4%→1.9%,P=0.007),取出率降低(20%→2.9%,P=0.037),但一项研究报告血清肿率升高(4.7% vs 1.4%,P=0.033)。
关键数值与推荐
- 硫酸钙抗生素珠:植入物丢失率1.6% vs 9.4%(P=0.031)和1.5% vs 11.9%(P=0.024)。
- 聚甲基丙烯酸甲酯抗生素板:SSI率12.6%→4.8%(P<0.01)和14%→4%(P=0.047);植入物丢失率6% vs 18%(P=0.036)。
- 持续术后抗生素冲洗:SSI率6.4%→1.9%(P=0.007);取出率20%→2.9%(P=0.037);血清肿率4.7% vs 1.4%(P=0.033)。
临床怎么用
- 局部抗生素递送系统可能作为植入物乳房再造感染预防的辅助手段,但需结合患者个体情况谨慎选择。
- 使用持续术后抗生素冲洗时需警惕血清肿风险增加。
局限性
- 纳入研究均为回顾性设计,存在方法学局限,无法得出确定性结论。
- 需要前瞻性研究确认疗效、安全性和临床价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infection is a major complication of implant-based breast reconstruction (IBBR), leading to implant loss, increased healthcare costs, and poor outcomes. Local antibiotic delivery systems offer targeted infection prevention by providing sustained antibiotic release at the surgical site. The aim of this study is to review the existing literature on the efficacy of local antibiotic delivery systems in preventing infection in IBBR. METHODS: A systematic review following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines was conducted in Medline, Cochrane, and Embase (1990-2025). Studies assessing local antibiotic delivery in IBBR were included, while those evaluating systemic antibiotics, augmentation, and salvage procedures were excluded. Data on infection rates, implant loss, and complications were extracted and analyzed. RESULTS: Of 163 identified articles, 6 met inclusion criteria. Two studies examined calcium sulfate biodegradable antibiotic beads, which significantly lower implant loss rates (1.6% vs 9.4%, P = 0.031 and 1.5% vs 11.9%, P = 0.024). Two studies on polymethylmethacrylate antibiotic plates showed significant SSI reduction from 12.6% to 4.8% ( P < 0.01) and from 14% to 4% ( P = 0.047), with implant loss rates significantly lower in polymethylmethacrylate cohort (6% vs 18%, P = 0.036). Continuous postoperative antibiotic irrigation studies demonstrated SSI reduction from 6.4% to 1.9% ( P = 0.007) and decreased explant rate from 20% to 2.9% ( P = 0.037), but one study reported a higher seroma rate (4.7% vs 1.4%, P = 0.033). CONCLUSIONS: Preliminary studies suggest local antibiotic delivery may reduce infection and implant loss in breast reconstruction, but retrospective designs and methodological limitations preclude definitive conclusions. Prospective studies are needed to confirm efficacy, safety, and clinical value.
引用
- Graziano FD, Shammas RL, Mehrara BJ, et al. Local Antibiotic Delivery Systems for Infection Prophylaxis in Implant-Based Breast Reconstruction: What Is the Evidence? Ann Plast Surg. 2025. PMID: 40532235. doi:10.1097/SAP.0000000000004416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。